|
Volumn 289, Issue 21, 2003, Pages 2801-2809
|
Clinical Features and Short-term Outcomes of 144 Patients with SARS in the Greater Toronto Area
b b a,b,f b,c b,d b,e a,b,f a,b b,g b,g b,h b,i b,j b,c b,f a,b,f b,k b b a,b more.. |
Author keywords
[No Author keywords available]
|
Indexed keywords
LACTATE DEHYDROGENASE;
RIBAVIRIN;
ANTIINFLAMMATORY AGENT;
ANTIVIRUS AGENT;
BIOLOGICAL MARKER;
HYDROCORTISONE;
ADULT;
ARTICLE;
ARTIFICIAL VENTILATION;
BRADYCARDIA;
CANADA;
CLINICAL FEATURE;
COMORBIDITY;
CONFIDENCE INTERVAL;
COUGHING;
DYSPNEA;
FEMALE;
FEVER;
HEMOLYSIS;
HUMAN;
HYPOCALCEMIA;
INTENSIVE CARE;
LYMPHOCYTOPENIA;
MAJOR CLINICAL STUDY;
MALE;
MULTIVARIATE ANALYSIS;
MYALGIA;
PRIORITY JOURNAL;
RHINORRHEA;
SELF REPORT;
SEVERE ACUTE RESPIRATORY SYNDROME;
SIDE EFFECT;
SORE THROAT;
VIRUS PNEUMONIA;
AGED;
BLOOD;
COMMUNICABLE DISEASE;
DEMOGRAPHY;
DISEASE COURSE;
EPIDEMIC;
HOSPITALIZATION;
INFECTION CONTROL;
INTENSIVE CARE UNIT;
ISOLATION AND PURIFICATION;
LUNG;
MIDDLE AGED;
NONPARAMETRIC TEST;
PROPORTIONAL HAZARDS MODEL;
RADIOGRAPHY;
RETROSPECTIVE STUDY;
SARS CORONAVIRUS;
SURVIVAL;
ADULT;
AGED;
ANTI-INFLAMMATORY AGENTS;
ANTIVIRAL AGENTS;
BIOLOGICAL MARKERS;
COMMUNICABLE DISEASES, EMERGING;
COMORBIDITY;
COUGH;
DEMOGRAPHY;
DISEASE OUTBREAKS;
DISEASE PROGRESSION;
DYSPNEA;
FEMALE;
FEVER;
HOSPITALIZATION;
HUMANS;
HYDROCORTISONE;
INFECTION CONTROL;
INTENSIVE CARE UNITS;
LUNG;
MALE;
MIDDLE AGED;
ONTARIO;
PROPORTIONAL HAZARDS MODELS;
RESPIRATION, ARTIFICIAL;
RETROSPECTIVE STUDIES;
RIBAVIRIN;
SARS VIRUS;
SEVERE ACUTE RESPIRATORY SYNDROME;
STATISTICS, NONPARAMETRIC;
SURVIVAL ANALYSIS;
|
EID: 0037976821
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.289.21.JOC30885 Document Type: Article |
Times cited : (1198)
|
References (24)
|